Cargando…
Bupropion and Citalopram in the APP23 Mouse Model of Alzheimer's Disease: A Study in a Dry-Land Maze
Background. Incipient Alzheimer's disease is often disguised as depressive disorder. Over the course of AD, depressive symptoms are even more frequent. Hence, treatment with antidepressants is common in AD. It was the goal of the present study to assess whether two common antidepressants with d...
Autores principales: | Neumeister, Katharina L., Riepe, Matthias W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465969/ https://www.ncbi.nlm.nih.gov/pubmed/23056993 http://dx.doi.org/10.1155/2012/673584 |
Ejemplares similares
-
The effects of Gouqi extracts on Morris maze learning in the APP/PS1 double transgenic mouse model of Alzheimer’s disease
por: ZHANG, QIANLIN, et al.
Publicado: (2013) -
The Maze of APP Processing in Alzheimer’s Disease: Where Did We Go Wrong in Reasoning?
por: Chen, Ming
Publicado: (2015) -
PS124. Effects of desipramine, venlafaxine and bupropion on depression and anxiety in the forced swimming test and elevated plus maze test in mice
por: Tanyeri, Mehmet Hanifi, et al.
Publicado: (2016) -
Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro
por: Sager, Jennifer E., et al.
Publicado: (2016) -
Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial
por: Maier, Franziska, et al.
Publicado: (2020)